4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001507567-23-000003
Options or other derivatives
- Director acquired 67,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Booth Robert F. · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-03 | Grant or award : show line 1 in the form Stock Option (right to buy) | +35,000 | 35,000 | D | ||
| 2023-01-03 | Grant or award : show line 2 in the form Stock Option (right to buy) | +32,700 | $1.67 | $54,609 | 67,700 | D |
Loading xslF345X03/wf-form4_167295366118350.xml…